MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-03-0003365
Medicita Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹17.04 Cr
▲ 30% YoY
Net profit · FY 2024
₹98.78 Lakh
Net margin 5.8%
EBITDA · FY 2024
₹1.58 Cr
EBITDA margin 9.3%
Authorised capital
₹11 Lakh
Registered with MCA
Paid-up capital
₹11 Lakh
Issued & subscribed
Open charges
₹4.22 Cr
Satisfied ₹8.98 Lakh
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Medicita Pharma Private Limited
Data last updated:
Medicita Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC304318. Its GSTIN is 07AAKCM4978L1ZO (Delhi).
The company has an authorised share capital of ₹11 Lakh and a paid-up capital of ₹11 Lakh. It is led by directors Ajay Kumar and Arun Kumar Saraswat.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot 307 Fie Patpadganj, Industrial Area, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.04 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹98.78 Lakh (net margin 5.8%) and EBITDA of ₹1.58 Cr (EBITDA margin 9.3%). Revenue has grown at a compounded annual rate (CAGR) of 104% over three years and 50% over five years.
As per MCA filings, the company has open charges of ₹4.22 Cr and satisfied charges of ₹8.98 Lakh on record.
Medicita Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0003365). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medicitapharma.com.
Company details
CIN U74999DL2016PTC304318
Registration Number 304318
Incorporation Date 11 August 2016
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-03-0003365
Key People
Ajay Kumar Director Arun Kumar Saraswat Director Recognitions & Rankings of Medicita Pharma
Contact details
Medicita Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is medicitapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot 307 Fie Patpadganj, Industrial Area, New Delhi, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medicita Pharma Private Limited, buy the company report.
Comprehensive company report
Medicita Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medicita Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Medicita Pharma Private Limited, buy the company report.
Financials of Medicita Pharma Private Limited
FY 2024 filings availableMedicita Pharma Private Limited reported revenue of ₹17.04 Cr (up 30% YoY) for FY 2024.
Revenue · FY 2024
₹17.04 Cr ▲ 30%
Net profit · FY 2024
₹98.78 Lakh margin 5.8%
EBITDA · FY 2024
₹1.58 Cr margin 9.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 104%
5 years · compounded
▲ 50%
EBITDA CAGR growth
1 year
▲ 41%
3 years · compounded
▲ 85%
5 years · compounded
▲ 45%
Revenue has grown at a compounded annual rate (CAGR) of 50% over five years, including 30% growth in the latest year. EBITDA rose 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.58 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹98.78 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.3% | ||||
| Net Profit Margin | 5.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medicita Pharma Private Limited, buy the company report.
Board of directors of Medicita Pharma Private Limited
Medicita Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Kumar Also directs: Seanan Laboratories Private Limited | Director | 11 Aug 2016 | 10 Years 2 Months | Current |
| Arun Kumar Saraswat Also directs: Seanan Laboratories Private Limited, Commbiio Foundation | Director | 27 Apr 2022 | 4 Years 5 Months | Current |
Auditor
Medicita Pharma Private Limited is audited by AGARWAL CHIRAG & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGARWAL CHIRAG & ASSOCIATES | FY 2023 | 023691C |
Shareholding
The shareholding of Medicita Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medicita Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.22 Cr
Satisfied charges
₹8.98 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Oct 2024 | 100997041 | State Bank of India | ₹22 Lakh | Open | |
| 11 Mar 2024 | 100894388 | State Bank of India | ₹4 Cr | Open | |
| 19 Apr 2024 | 100909345 | State Bank of India | ₹8.98 Lakh | Satisfied |
To see the full charge records of Medicita Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Medicita Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medicita Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medicita Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAKCM4978L1ZO | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medicita Pharma Private Limited, buy the company report.
Recent activity
Medicita Pharma Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Arun Kumar Saraswat ceased to be Additional Director on 30 Sep 2022.
Charges
A charge registered on 19 Apr 2024 via Charge ID 100909345 with State Bank Of India was fully satisfied on 23 Oct 2024.
Charges
A charge with State Bank Of India amounted to Rs. 22.00 Lakh with Charge ID 100997041 was registered on 18 Oct 2024.
AGM
Medicita Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with State Bank Of India amounted to Rs. 8.98 Lakh with Charge ID 100909345 was registered on 19 Apr 2024.
Filing
Medicita Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with State Bank Of India amounted to Rs. 400.00 Lakh with Charge ID 100894388 was registered on 11 Mar 2024.
Ceased
Arun Kumar Saraswat ceased to be Additional Director.
Appointed
Arun Kumar Saraswat was appointed as Director.
Ceased
Durgesh Sarswat ceased to be Director.
Ceased
Jamshed Alam Ansari ceased to be Director.
Appointed
Ajay Kumar was appointed as Director.
Incorporation
11 Aug 2016
Medicita Pharma Private Limited was registered on 11 Aug 2016 with Roc Delhi & aged 10 years 2 months as per MCA records.
Frequently asked questions
Medicita Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 August 2016 (10+ years old) and is registered under CIN U74999DL2016PTC304318.
Medicita Pharma has 2 current directors:
- Ajay Kumar - Director
- Arun Kumar Saraswat - Director
The latest financial statements of Medicita Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Medicita Pharma is 07AAKCM4978L1ZO, registered in Delhi.
The CIN (Corporate Identification Number) of Medicita Pharma is U74999DL2016PTC304318. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medicita Pharma was incorporated on 11 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
Arun Kumar Saraswat ceased to be Additional Director on 30 Sep 2022. Arun Kumar Saraswat was appointed as Director on 27 Apr 2022. Durgesh Sarswat ceased to be Director on 27 Apr 2022. Medicita Pharma has 5 board changes on record in total.
Yes, Medicita Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-DL-03-0003365).
Medicita Pharma can be reached through the website medicitapharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Medicita Pharma is at Plot 307 Fie Patpadganj, Industrial Area, New Delhi, Delhi, India – 110092.